Arrowhead Pharmaceuticals
ARWR
#1766
Rank
NZ$20.81 B
Marketcap
NZ$147.78
Share price
-1.36%
Change (1 day)
460.40%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): NZ$1.60

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ$1.40. In 2025 the company made an earnings per share (EPS) of NZ-$0.01726 an increase over its 2024 EPS that were of NZ-$8.63.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.60-9359.7%
2025NZ-$0.01726-99.8%
2024NZ-$8.63161.39%
2023NZ-$3.3017.36%
2022NZ-$2.8119.85%
2021NZ-$2.3561.9%
2020NZ-$1.45-216.67%
2019NZ$1.24-210.77%
2018NZ-$1.1238.3%
2017NZ-$0.81-64.93%
2016NZ-$2.31-16.25%
2015NZ-$2.7628%
2014NZ-$2.16-3.85%
2013NZ-$2.24-31.58%
2012NZ-$3.28331.82%
2011NZ-$0.76-51.11%
2010NZ-$1.55-79.07%
2009NZ-$7.42-37.68%
2008NZ-$11.91-16.87%
2007NZ-$14.3338.33%
2006NZ-$10.36122.22%
2005NZ-$4.6642.11%
2004NZ-$3.28533.33%
2003NZ-$0.52-99.08%
2002NZ-$56.0525%
2001NZ-$44.8433.33%
2000NZ-$33.63-120%
1999NZ$168.16-400%
1998NZ-$56.05-81.48%
1997NZ-$302.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.08 978.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ-$14.07-1,106.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$13.53 867.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$6.54 367.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
NZ-$3.92-380.25%๐Ÿ‡บ๐Ÿ‡ธ USA